Abstract
This document is a process and design evaluation intended to offer insights and lessons to the international development community by appraising the design process, design decisions, and implementation of the Pneumococcal Advance Market Commitment to date. The Terms of Reference (TOR) for this evaluation, which are reproduced in Annex I, were developed by the AMC stakeholders and set out in the RFP document4 dated February 2012. The TOR requires this evaluation to focus on 1) design process, 2) technical design elements, and 3) implementation, taking into account the available evidence for progress achieved toward the Pilot’s objectives.
This evaluation focuses on how the key decisions that were made when designing and implementing the Pneumococcal AMC have contributed towards fulfilling the objectives of the AMC Pilot. Our analysis is limited to the immediate consequences of the Pilot’s specific design choices, leaving the broader discussion of its overall impact to an outcome evaluation to be commissioned by the GAVI Secretariat in 2014. This evaluation utilized more than 440 documents, including the AMC Baseline study, more than 50 interviews, and a number of analytical methods to reach the conclusions that follow. Further discussion of the scope and methodology of this report are included in the Methodology chapter (Page 20).
